In vitro antidiabetic activity of Peperomia pellucida extract and fraction by alpha-amylase inhibition pathway

Authors

  • Sholihatil Hidayati Universitas dr. Soebandi
  • Shinta Shinta Mayasari Universitas dr. Soebandi
  • Lindawati Setyaningrum Universitas dr. Soebandi
  • Ayu Dwi Wardani Universitas dr. Soebandi
  • Qurrotul Aini Universitas dr. Soebandi

DOI:

https://doi.org/10.12928/pharmaciana.v12i2.21874

Keywords:

Peperomia pellucida, alpha-amylase, total flavonoid content, ethanol extract, ethyl acetate fraction

Abstract

The development of type 2 diabetes is influenced by the important role of post-prandial blood glucose management. One strategy in controlling post-prandial hyperglycemia can be done by inhibiting the digestion of dietary carbohydrates through inhibition of alpha amylase enzyme. Natural alpha amylase enzyme inhibition strategy that utilizes natural ingredients is an important alternative in the development of antidiabetic drugs. One of the plants that has the potential to be developed as an antidiabetic is Peperomia pellucida. This study aims to examine the effects of antidiabetic extracts and fractions of Peperomia pellucida in inhibiting alpha amylase enzyme. The research was conducted by determining the total flavonoid using quercetin standard. Antidiabetic studies were carried out by looking at the activity of extracts and fractions of Peperomia pellucida in inhibiting alpha amylase enzyme using visible spectrophotometry method. Data analysis was performed by entering the absorbance value into the standard quercetin curve, while the IC50 value of in vitro antidiabetic activity was determined by entering the value 50 on the curve between the sample concentration and % inhibition of the alpha amylase enzyme. The results showed that the total flavonoid values of the ethanol extract and the ethyl acetate fraction of the herb were 88.24 mg QE/g extract and 80.45 mg QE/g fraction, respectively. Based on the results, the inhibition of alpha amylase enzyme showed that the ethanol extract and the ethyl acetate fraction of the herbs had inhibitory activity with the IC50 value of the ethanol extract 1065.54 g/mL and the ethyl acetate fraction 906.53 g/mL. While the control of acarbose showed an IC50 value of 379.45 g/mL. The ethanol extract and the ethyl acetate fraction of Peperomia pellucida herbs have the potential to be developed as antidiabetic agents with the mechanism of action of inhibiting the activity of the alpha amylase enzyme.

Author Biography

Sholihatil Hidayati, Universitas dr. Soebandi

Farmasi klinik dan komunitas

References

Abdi, A., Jalilian, M., Sarbarzeh, P. A., & Vlaisavljevic, Z. (2020). Diabetes and COVID-19: A systematic review on the current evidences. In Diabetes Research and Clinical Practice (Vol. 166). Elsevier Ireland Ltd. https://doi.org/10.1016/j.diabres.2020.108347

Adeloye, D., Ige, J. O., Aderemi, A. V, Adeleye, N., Amoo, E. O., Auta, A., & Oni, G. (2017). Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis. BMJ Open, 7(5), e015424.

Alagesan, K., Raghupathi, P. K., & Sankarnarayanan, S. (2012). Amylase inhibitors: potential source of anti-diabetic drug discovery from medicinal plants. Int J Pharm Life Sci, 3(2), 1407–1412.

Ali, E., Mohamed, H., Jamshed, M., Siddiqui, A., Ang, L. F., Sadikun, A., Chan, S. H., Choon Tan, S., Asmawi, M. Z., & Yam, M. F. (2012). Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism. http://www.biomedcentral.com/1472-6882/12/176

Alongi, M., & Anese, M. (2018). Effect of coffee roasting on in vitro α-glucosidase activity: Inhibition and mechanism of action. Food Research International, 111, 480–487. https://doi.org/10.1016/j.foodres.2018.05.061

Alqahtani, A. S., Hidayathulla, S., Rehman, M. T., Elgamal, A. A., Al-Massarani, S., Razmovski-Naumovski, V., Alqahtani, M. S., El Dib, R. A., & Alajmi, M. F. (2020). Alpha-amylase and alpha-glucosidase enzyme inhibition and antioxidant potential of 3-oxolupenal and katononic acid isolated from Nuxia oppositifolia. Biomolecules, 10(1). https://doi.org/10.3390/biom10010061

Daud, M. A., Abrar, M., Dokter Hewan Fakultas Kedokteran Hewan Universitas Syiah Kuala, P., Aceh, B., Pangan Fakultas Teknologi Pertanian Universitas Serambi ekkah, T. M., & Aceh Alamat, B. (2019). α-Amylase And α-Glucosidase Inhibitors From Plant Extracts. https://doi.org/10.21157/j.med.vet.v11i1.13819

David, A. V. A., Arulmoli, R., & Parasuraman, S. (2016). Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacognosy Reviews, 10(20), 84.

Hosseini, A., Razavi, B. M., Banach, M., & Hosseinzadeh, H. (2021). Quercetin and metabolic syndrome: A review. Phytotherapy Research.

Martinez-Gonzalez, A. I., Díaz-Sánchez, G., de la Rosa, L. A., Bustos-Jaimes, I., & Alvarez-Parrilla, E. (2019). Inhibition of α-amylase by flavonoids: Structure activity relationship (SAR). Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 206, 437–447. https://doi.org/10.1016/j.saa.2018.08.057

Moein, S., Pimoradloo, E., Moein, M., & Vessal, M. (2017). Evaluation of Antioxidant Potentials and α-Amylase Inhibition of Different Fractions of Labiatae Plants Extracts: As a Model of Antidiabetic Compounds Properties. BioMed Research International, 2017. https://doi.org/10.1155/2017/7319504

Sales, P. M., Souza, P. M., Simeoni, L. A., Magalhães, P. O., & Silveira, D. (2012). α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. Journal of Pharmacy & Pharmaceutical Sciences, 15(1), 141–183.

Shai, L. J., Masoko, P., Mokgotho, M. P., Magano, S. R., Mogale, A. M., Boaduo, N., & Eloff, J. N. (2010). Yeast alpha glucosidase inhibitory and antioxidant activities of six medicinal plants collected in Phalaborwa, South Africa. South African Journal of Botany, 76(3), 465–470.

Tadera, K., Minami, Y., Takamatsu, K., & Matsuoka, T. (2006). Inhibition of-Glucosidase and-Amylase by Flavonoids. In J Nutr Sci Vitaminol (Vol. 52).

Takahama, U., & Hirota, S. (2018). Interactions of flavonoids with α-amylase and starch slowing down its digestion. In Food and Function (Vol. 9, Issue 2, pp. 677–687). Royal Society of Chemistry. https://doi.org/10.1039/c7fo01539a

Trinh, B. T. D., Staerk, D., & Jäger, A. K. (2016). Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes. Journal of Ethnopharmacology, 186, 189–195. https://doi.org/10.1016/j.jep.2016.03.060

Tundis, R., Loizzo, M. R., & Menichini, F. (2010). Natural Products as-Amylase and-Glucosidase Inhibitors and their Hypoglycaemic Potential in the Treatment of Diabetes: An Update. In Reviews in Medicinal Chemistry (Vol. 10).

Wang, T. yang, Li, Q., & Bi, K. shun. (2017). Bioactive flavonoids in medicinal plants: Structure, activity and biological fate. In Asian Journal of Pharmaceutical Sciences (Vol. 13, Issue 1, pp. 12–23). Shenyang Pharmaceutical University. https://doi.org/10.1016/j.ajps.2017.08.004

Wulandari, L., Nugraha, A. S., & Azhari, N. P. (2020). Penentuan Aktivitas Antioksidan dan Antidiabetes Ekstrak Daun Kepundung (Baccaurea racemosa Muell.Arg.) secara In Vitro. Jurnal Sains Farmasi & Klinis, 7(1), 60. https://doi.org/10.25077/jsfk.7.1.60-66.2020

Zhu, J., Chen, C., Zhang, B., & Huang, Q. (2020). The inhibitory effects of flavonoids on α-amylase and α-glucosidase. In Critical Reviews in Food Science and Nutrition (Vol. 60, Issue 4, pp. 695–708). Taylor and Francis Inc. https://doi.org/10.1080/10408398.2018.1548428

Downloads

Published

2022-07-04

Issue

Vol. 12 No. 2 (2022): Pharmaciana

Section

Analytical Pharmacy and Medicinal Chemistry

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.